Advocacy
How are we advocating for Kidney Cancer? Find out HERE
In the News
What’s the latest in the news regarding Kidney Cancer? Read below
This Week: RADVAX at ASCO GU
We are so proud to see Dr. Hans Hammers's clinical trial of RADVAX selected for presentation at ASCO GU 2020. ASCO is the American Society of Clinical Oncology, and ASCO GU focuses on genitourinary cancers.
What Kidney Cancer Research Looks Like: SUNY Upstate Medical University
In January, the KidneyCAN team traveled to Syracuse, New York to visit the SUNY (State University of New York) Upstate Medical University and met with Dr. Gennady Bratslavsky and his team at the urology
A New Era for the FDA: Our Perspective
In the past, the work of the Food and Drug Administration was often bogged down by bureaucratic processes and the red tape of a regulatory environment. The drug approval department could be inefficient, and it
Clinical Trials Save Lives: Gary’s RADVAX Story
January is Clinical Trial Awareness Month. Today, we're featuring a story from Gary Cole, our friend and a kidney cancer patient. He shares his experience with the RADVAX clinical trial, funded by KidneyCAN thanks to
Spring 2020 D.C. Advocacy Days
In March of 2019, KidneyCAN sponsored the Kidney Cancer Advocacy Day in D.C. This successful event was attended by more than 20 kidney cancer patient advocates from various parts of the country. We had more
Do Something: The Importance of Patient Advocacy in Healthcare
"What strikes me about these individuals and many others I have met in the community is the personal will to 'do something.' The disease eliminates so much of our sense of agency that
Our Communities
Smart Patients is an online community where patients and their families learn from each other. Patients can be extraordinarily knowledgeable about their disease. Get information and support from patients who have expertise to share with you.
Please enter your information below: